Lung Function Responder Rates in the Voyage Study in Children with Moderate-to-severe Type 2 Asthma Receiving Dupilumab

被引：0
|
作者：
Guilbert, T. W. [1 ,2 ]
Fiocchi, A. G. [3 ]
Murphy, K. R. [4 ]
Hamelmann, E. [5 ]
Ross, K. [6 ]
Gupta, A. [7 ]
Xia, C. [8 ]
Gall, R. [8 ]
Ledanois, O. [9 ]
Radwan, A. [8 ]
Jacob-Nara, J. A. [10 ]
Rowe, P. J. [10 ]
Deniz, Y. [8 ]
机构：
[1] Cincinnati Childrens Hosp, Cincinnati, OH USA
[2] Univ Cincinnati, Cincinnati, OH USA
[3] Bambino Gesu Childrens Hosp IRCCS, Rome, Italy
[4] Boys Town Natl Res Hosp, Boys Town, NE USA
[5] Univ Bielefeld, Bielefeld, Germany
[6] Case Western Reserve Univ, Cleveland, OH USA
[7] Kings Coll Hosp London, London, England
[8] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[9] Sanofi, Paris, France
[10] Sanofi, Bridgewater, France
来源：
PEDIATRIC PULMONOLOGY | 2023年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
A 10
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [31] Dupilumab in children with moderate-to-severe asthma: A cost utility analysis
    Buendia, Jefferson A.
    Patino, Diana G.
    PEDIATRIC PULMONOLOGY, 2022, 57 (10) : 2313 - 2319
  • [32] Dupilumab long term efficacy in children with moderate-to-severe type 2 asthma with/without evidence of allergic asthma
    Phipatanakul, W.
    Prenzel, F.
    Papadopoulos, N. G.
    Bacharier, L. B.
    Hamelmann, E.
    Fiocchi, A. G.
    Altincatal, A.
    Gall, R.
    Ledanois, O.
    KLINISCHE PADIATRIE, 2024, 236 (02): : S3 - S4
  • [33] Dupilumab efficacy in VOYAGE pediatric patients with uncontrolled, moderate-to-severe type 2 inflammatory asthma by allergen sensitization status
    Phipatanakul, W.
    Papadopoulos, N. G.
    Hernandez-Trujillo, V.
    Hamelmann, E.
    Zeiger, R. S.
    Ducharme, F. M.
    Jain, N.
    Xia, C.
    Gall, R.
    Pandit-Abid, N.
    Siddiqui, S.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    ALLERGOLOGIE, 2022, 45 (08) : 604 - 604
  • [34] Improved Lung Function is Associated With Better Asthma Control in Children Aged 6 to 11 Years With Moderate-To-Severe Type 2 Asthma: A Post Hoc Analysis of VOYAGE
    Bacharier, Leonard
    Dell, Sharon
    de Mir-Messa, Ines
    Piacentini, Giorgio
    Hamelmann, Eckard
    Msihid, Jerome
    Gall, Rebecca
    Ledanois, Olivier
    Wang, Zhixiao
    Cheng, Wei-Han
    Sacks, Harry
    Jacob-Nara, Juby
    Rowe, Paul
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB99 - AB99
  • [35] Improved lung function is associated with better asthma control in children aged 6 to 11 years with moderate-to-severe type 2 asthma: A post hoc analysis of VOYAGE
    Bacharier, L. B.
    Gerstlauer, M.
    Dell, S. D.
    de Mir, I
    Piacentini, G.
    Hamelmann, E.
    Msihid, J.
    Gall, R.
    Ledanois, O.
    Wang, Z.
    Cheng, W. -H.
    Sacks, H.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    KLINISCHE PADIATRIE, 2024, 236 (02): : S3 - S3
  • [36] Efficacy of dupilumab 200 mg every 2 weeks in children with moderate-to-severe asthma: A post hoc analysis of voyage and excursion
    Phipatanakul, W.
    Jackson, D.
    Vogelberg, C.
    Bacharier, L.
    Dell, S. D.
    Altincatal, A.
    Gall, R.
    Ledanois, O.
    Sacks, H.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    ALLERGY, 2023, 78 : 265 - 265
  • [37] Dupilumab Impact on Lung Function in Children with Uncontrolled, Moderate- To- Severe Asthma and Elevated Type 2 Biomarkers
    Guilbert, T. W.
    Bacharier, L. B.
    Deschildre, A.
    Phipatanakul, W.
    Altincatal, A.
    Mannent, L.
    Amin, N.
    Laws, E.
    Akinlade, B.
    Ortiz, B.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    Lederer, D. J.
    Hardin, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [38] Impact of dupilumab across seasons in patients with type 2, uncontrolled, moderate-to-severe asthma
    Peters, Anju T.
    Sagara, Hironori
    Corren, Jonathan
    Domingo, Christian
    Altincatal, Arman
    Soler, Xavier
    Pandit-Abid, Nami
    Crikelair, Nora
    Rowe, Paul J.
    Jacob-Nara, Juby A.
    Deniz, Yamo
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 132 (04) : 477 - 484.e4
  • [39] Late Breaking Abstract- Clinical remission with dupilumab in children with uncontrolled, moderate-to-severe, type 2 asthma
    Bacharier, Leonard
    Guilbert, Theresa W.
    Maspero, Jorge F.
    Gappa, Monika
    Dell, Sharon
    Altincatal, Arman
    Ledanois, Olivier
    Gall, Rebecca
    Sacks, Harry
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [40] Dupilumab Improved Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma Despite Exacerbation Events During the LIBERTY ASTHMA QUEST Study
    Rabe, K. F.
    Castro, M.
    Wenzel, S. E.
    Corren, J.
    Pavord, I. D.
    Katelaris, C.
    Tohda, Y.
    Rice, M. S.
    Lu, Y.
    Rowe, P.
    Staudinger, H. W.
    Amin, N.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345